{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:18:35Z","timestamp":1783333115800,"version":"3.54.6"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP.1\/167\/46"],"award-info":[{"award-number":["RGP.1\/167\/46"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-026-02511-2","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T10:18:46Z","timestamp":1774347526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational Repurposing of Nilotinib and Radotinib as SIRT2 Inhibitors for Neurodegenerative Diseases"],"prefix":"10.1007","volume":"76","author":[{"given":"Taghreed A.","family":"Majrashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Y.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moady Ahmad","family":"Asiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Zia-Ul-Sabah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abohassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devesh U.","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadma","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2511_CR43","doi-asserted-by":"publisher","first-page":"245102","DOI":"10.1063\/1.2945165","volume":"128","author":"A Altis","year":"2008","unstructured":"Altis A, Otten M, Nguyen PH, Hegger R, Stock G (2008) Construction of the free energy landscape of biomolecules via dihedral angle principal component analysis. J Chem Phys 128:245102. https:\/\/doi.org\/10.1063\/1.2945165","journal-title":"J Chem Phys"},{"key":"2511_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s13659-020-00267-9","volume":"10","author":"S Ashique","year":"2020","unstructured":"Ashique S, Sandhu NK, Haque SN, Koley K (2020) A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review, Nat. Prod Bioprospect 10:345\u2013365. https:\/\/doi.org\/10.1007\/s13659-020-00267-9","journal-title":"Prod Bioprospect"},{"key":"2511_CR21","doi-asserted-by":"publisher","first-page":"102186","DOI":"10.1016\/j.apmt.2024.102186","volume":"38","author":"VK Bhardwaj","year":"2024","unstructured":"Bhardwaj VK, Purohit R (2024) Potential acridinedione derivatives for the development of a heterobifunctional PROTAC for targeted degradation of PCSK9 protein. Appl Mater Today 38:102186. https:\/\/doi.org\/10.1016\/j.apmt.2024.102186","journal-title":"Appl Mater Today"},{"key":"2511_CR28","doi-asserted-by":"publisher","first-page":"W252","DOI":"10.1093\/nar\/gku340","volume":"42","author":"M Biasini","year":"2014","unstructured":"Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Cassarino TG, Bertoni M, Bordoli L, Schwede T (2014) SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42:W252\u2013W258. https:\/\/doi.org\/10.1093\/nar\/gku340","journal-title":"Nucleic Acids Res"},{"key":"2511_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1124\/pr.110.003905","volume":"64","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3 C, Auwerx J (2012) Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+? Pharmacol Rev 64:166\u2013187. https:\/\/doi.org\/10.1124\/pr.110.003905","journal-title":"Pharmacol Rev"},{"key":"2511_CR54","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1021\/acs.jpcb.8b02144","volume":"122","author":"MC Childers","year":"2018","unstructured":"Childers MC, Daggett V (2018) Validating Molecular Dynamics Simulations against Experimental Observables in Light of Underlying Conformational Ensembles. J Phys Chem B 122:6673\u20136689. https:\/\/doi.org\/10.1021\/acs.jpcb.8b02144","journal-title":"J Phys Chem B"},{"key":"2511_CR3","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.3390\/ijms10062510","volume":"10","author":"YES Choonara","year":"2009","unstructured":"Choonara Y.E., Pillay V, Du Toit LC, Modi G, Naidoo D, Ndesendo VMK, Sibambo SR (2009) Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders. IJMS 10:2510\u20132557. https:\/\/doi.org\/10.3390\/ijms10062510","journal-title":"IJMS"},{"key":"2511_CR9","doi-asserted-by":"publisher","first-page":"i22","DOI":"10.1136\/jnnp.72.suppl_1.i22","volume":"72","author":"CE Clarke","year":"2002","unstructured":"Clarke CE, MEDICAL MANAGEMENT OF PARKINSON\u2019S DISEASE (2002) J Neurol Neurosurg Psychiatry 72:i22\u2013i27. https:\/\/doi.org\/10.1136\/jnnp.72.suppl_1.i22","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2511_CR32","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano WL (2002) Pymol: An open-source molecular graphics tool, CCP4 Newsl. Protein Crystallogr 40:82\u201392","journal-title":"Protein Crystallogr"},{"key":"2511_CR10","first-page":"504","volume":"40","author":"G DeMaagd","year":"2015","unstructured":"DeMaagd G, Philip A (2015) Parkinson\u2019s Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis. P T 40:504\u2013532","journal-title":"P T"},{"key":"2511_CR20","doi-asserted-by":"publisher","first-page":"123504","DOI":"10.1016\/j.molliq.2023.123504","volume":"392","author":"A Dhiman","year":"2023","unstructured":"Dhiman A, Purohit R (2023) Targeting tachykinin peptides involved in viral infections through in silico approach: Screening the unforeseen potency of serratiopeptidase. J Mol Liq 392:123504. https:\/\/doi.org\/10.1016\/j.molliq.2023.123504","journal-title":"J Mol Liq"},{"key":"2511_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/03639045.2019.1576724","volume":"45","author":"DG Gadhave","year":"2019","unstructured":"Gadhave DG, Kokare CR (2019) Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies. Drug Dev Ind Pharm 45:839\u2013851. https:\/\/doi.org\/10.1080\/03639045.2019.1576724","journal-title":"Drug Dev Ind Pharm"},{"key":"2511_CR1","doi-asserted-by":"publisher","first-page":"148674","DOI":"10.1016\/j.brainres.2023.148674","volume":"1822","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Sugandhi VV, Kokare CR (2024) Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis. Brain Res 1822:148674. https:\/\/doi.org\/10.1016\/j.brainres.2023.148674","journal-title":"Brain Res"},{"key":"2511_CR38","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1110\/ps.03137003","volume":"12","author":"R Gargallo","year":"2003","unstructured":"Gargallo R, H\u00fcnenberger PH, Avil\u00e9s FX, Oliva B (2003) Molecular dynamics simulation of highly charged proteins: Comparison of the particle-particle particle\u2010mesh and reaction field methods for the calculation of electrostatic interactions. Protein Sci 12:2161\u20132172. https:\/\/doi.org\/10.1110\/ps.03137003","journal-title":"Protein Sci"},{"key":"2511_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"key":"2511_CR19","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.tips.2015.08.001","volume":"36","author":"P Gomes","year":"2015","unstructured":"Gomes P, Fleming Outeiro T, Cavadas C (2015) Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism. Trends Pharmacol Sci 36:756\u2013768. https:\/\/doi.org\/10.1016\/j.tips.2015.08.001","journal-title":"Trends Pharmacol Sci"},{"key":"2511_CR53","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3389\/fphar.2018.01089","volume":"9","author":"IA Guedes","year":"2018","unstructured":"Guedes IA, Pereira FSS, Dardenne LE (2018) Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges. Front Pharmacol 9:1089. https:\/\/doi.org\/10.3389\/fphar.2018.01089","journal-title":"Front Pharmacol"},{"key":"2511_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.procbio.2023.09.022","volume":"134","author":"A Gupta","year":"2023","unstructured":"Gupta A, Purohit R (2023) Unraveling the mechanistic details of rho-associated coiled-coil kinase1 (ROCK1) inhibition: Implications from pharmacophore mapping and free energy analysis. Process Biochem 134:112\u2013120. https:\/\/doi.org\/10.1016\/j.procbio.2023.09.022","journal-title":"Process Biochem"},{"key":"2511_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3988\/jcn.2009.5.3.120","volume":"5","author":"S-H Han","year":"2009","unstructured":"Han S-H (2009) Potential Role of Sirtuin as a Therapeutic Target for Neurodegenerative Diseases. J Clin Neurol 5:120. https:\/\/doi.org\/10.3988\/jcn.2009.5.3.120","journal-title":"J Clin Neurol"},{"key":"2511_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12264-022-00905-x","volume":"39","author":"P Huang","year":"2023","unstructured":"Huang P, Zhang M (2023) Magnetic Resonance Imaging Studies of Neurodegenerative Disease: From Methods to Translational Research. Neurosci Bull 39:99\u2013112. https:\/\/doi.org\/10.1007\/s12264-022-00905-x","journal-title":"Neurosci Bull"},{"key":"2511_CR4","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.3233\/JAD-221081","volume":"94","author":"BSM Hui","year":"2023","unstructured":"Hui BSM, Zhi LR, Retinasamy T, Arulsamy A, Law CSW, Shaikh MF, Yeong KY (2023) The Role of Interferon- \u03b1 in Neurodegenerative Diseases: A Systematic Review. J Alzheimer\u2019s Disease 94:S45\u2013S66. https:\/\/doi.org\/10.3233\/JAD-221081","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2511_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) Visual molecular dynamics. J Mol Graph 14:33\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"},{"key":"2511_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.semcdb.2021.01.005","volume":"116","author":"J Jim\u00e9nez-Balado","year":"2021","unstructured":"Jim\u00e9nez-Balado J, Eich TS (2021) GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer\u2019s disease. Semin Cell Dev Biol 116:146\u2013159. https:\/\/doi.org\/10.1016\/j.semcdb.2021.01.005","journal-title":"Semin Cell Dev Biol"},{"key":"2511_CR36","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nsb0902-646","volume":"9","author":"M Karplus","year":"2002","unstructured":"Karplus M, McCammon JA (2002) Molecular dynamics simulations of biomolecules. Nat Struct Biol 9:646\u2013652. https:\/\/doi.org\/10.1038\/nsb0902-646","journal-title":"Nat Struct Biol"},{"key":"2511_CR48","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1063\/1.438955","volume":"72","author":"R Krishnan","year":"1980","unstructured":"Krishnan R, Binkley JS, Seeger R, Pople JA (1980) Self-consistent molecular orbital methods. XX. A basis set for correlated wave functions. J Chem Phys 72:650\u2013654. https:\/\/doi.org\/10.1063\/1.438955","journal-title":"J Chem Phys"},{"key":"2511_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bioinformatics\/16.8.747","volume":"16","author":"A Lagunin","year":"2000","unstructured":"Lagunin A, Stepanchikova A, Filimonov D, Poroikov V (2000) PASS: prediction of activity spectra for biologically active substances. Bioinformatics 16:747\u2013748","journal-title":"Bioinformatics"},{"key":"2511_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/ijms23031851","volume":"23","author":"RNL Lamptey","year":"2022","unstructured":"Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J (2022) A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics. IJMS 23:1851. https:\/\/doi.org\/10.3390\/ijms23031851","journal-title":"IJMS"},{"key":"2511_CR18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s13311-013-0214-5","volume":"10","author":"B Langley","year":"2013","unstructured":"Langley B, Sauve A (2013) Sirtuin Deacetylases as Therapeutic Targets in the Nervous System. Neurotherapeutics 10:605\u2013620. https:\/\/doi.org\/10.1007\/s13311-013-0214-5","journal-title":"Neurotherapeutics"},{"key":"2511_CR51","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1093\/hmg\/ddy143","volume":"27","author":"S Lee","year":"2018","unstructured":"Lee S, Kim S, Park YJ, Yun SP, Kwon S-H, Kim D, Kim DY, Shin JS, Cho DJ, Lee GY, Ju HS, Yun HJ, Park JH, Kim WR, Jung EA, Lee S, Ko HS (2018) The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson\u2019s disease mouse model. Hum Mol Genet 27:2344\u20132356. https:\/\/doi.org\/10.1093\/hmg\/ddy143","journal-title":"Hum Mol Genet"},{"key":"2511_CR44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jmb.2008.10.018","volume":"385","author":"GG Maisuradze","year":"2009","unstructured":"Maisuradze GG, Liwo A, Scheraga HA (2009) Principal Component Analysis for Protein Folding Dynamics. J Mol Biol 385:312\u2013329. https:\/\/doi.org\/10.1016\/j.jmb.2008.10.018","journal-title":"J Mol Biol"},{"key":"2511_CR45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1021\/ct9005745","volume":"6","author":"GG Maisuradze","year":"2010","unstructured":"Maisuradze GG, Liwo A, Scheraga HA (2010) Relation between Free Energy Landscapes of Proteins and Dynamics. J Chem Theory Comput 6:583\u2013595. https:\/\/doi.org\/10.1021\/ct9005745","journal-title":"J Chem Theory Comput"},{"key":"2511_CR41","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jcc.540130805","volume":"13","author":"S Miyamoto","year":"1992","unstructured":"Miyamoto S, Kollman PA (1992) Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 13:952\u2013962. https:\/\/doi.org\/10.1002\/jcc.540130805","journal-title":"J Comput Chem"},{"key":"2511_CR31","doi-asserted-by":"publisher","first-page":"bbaa279","DOI":"10.1093\/bib\/bbaa279","volume":"22","author":"T Mohammad","year":"2021","unstructured":"Mohammad T, Mathur Y, Hassan MI (2021) InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening. Brief Bioinform 22:bbaa279","journal-title":"Brief Bioinform"},{"key":"2511_CR29","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"2511_CR12","doi-asserted-by":"publisher","unstructured":"Outeiro TF, Marques O, Kazantsev A (2008) Therapeutic role of sirtuins in neurodegenerative disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1782. 363\u2013369. https:\/\/doi.org\/10.1016\/j.bbadis.2008.02.010","DOI":"10.1016\/j.bbadis.2008.02.010"},{"key":"2511_CR50","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/jamaneurol.2019.4200","volume":"77","author":"FL Pagan","year":"2020","unstructured":"Pagan FL, Hebron ML, Wilmarth B, Torres-Yaghi Y, Lawler A, Mundel EE, Yusuf N, Starr NJ, Anjum M, Arellano J, Howard HH, Shi W, Mulki S, Kurd-Misto T, Matar S, Liu X, Ahn J, Moussa C (2020) Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol 77:309. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4200","journal-title":"JAMA Neurol"},{"key":"2511_CR5","doi-asserted-by":"publisher","first-page":"100095","DOI":"10.1016\/j.ejmcr.2022.100095","volume":"6","author":"S Pant","year":"2022","unstructured":"Pant S, Kapri A, Nain S (2022) Pyrimidine analogues for the management of neurodegenerative diseases. Eur J Med Chem Rep 6:100095. https:\/\/doi.org\/10.1016\/j.ejmcr.2022.100095","journal-title":"Eur J Med Chem Rep"},{"key":"2511_CR34","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J Med Chem 58:4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"2511_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168","journal-title":"Nat Rev Drug Discov"},{"key":"2511_CR49","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1063\/1.449360","volume":"83","author":"AE Reed","year":"1985","unstructured":"Reed AE, Weinhold F (1985) Natural localized molecular orbitals. J Chem Phys 83:1736\u20131740. https:\/\/doi.org\/10.1063\/1.449360","journal-title":"J Chem Phys"},{"key":"2511_CR30","doi-asserted-by":"publisher","first-page":"6263","DOI":"10.1038\/ncomms7263","volume":"6","author":"T Rumpf","year":"2015","unstructured":"Rumpf T, Schiedel M, Karaman B, Roessler C, North BJ, Lehotzky A, Ol\u00e1h J, Ladwein KI, Schmidtkunz K, Gajer M, Pannek M, Steegborn C, Sinclair DA, Gerhardt S, Ov\u00e1di J, Schutkowski M, Sippl W, Einsle O, Jung M (2015) Selective Sirt2 inhibition by ligand-induced rearrangement of the active site. Nat Commun 6:6263. https:\/\/doi.org\/10.1038\/ncomms7263","journal-title":"Nat Commun"},{"key":"2511_CR22","doi-asserted-by":"publisher","first-page":"101731","DOI":"10.1016\/j.mtchem.2023.101731","volume":"33","author":"B Sharma","year":"2023","unstructured":"Sharma B, Muthipeedika NJ, Bhattacherjee D, Zyryanov GV, Purohit R (2023) Multi-step synthesis of novel 2-methyl-3-carboxamide-4-quinolones and an enhanced sampling simulation method to identify potentiators for cystic fibrosis. Mater Today Chem 33:101731. https:\/\/doi.org\/10.1016\/j.mtchem.2023.101731","journal-title":"Mater Today Chem"},{"key":"2511_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/pr.112.007336","volume":"66","author":"G Sliwoski","year":"2014","unstructured":"Sliwoski G, Kothiwale S, Meiler J, Lowe EW (2014) Computational Methods in Drug Discovery. Pharmacol Rev 66:334\u2013395. https:\/\/doi.org\/10.1124\/pr.112.007336","journal-title":"Pharmacol Rev"},{"key":"2511_CR33","unstructured":"Studio D (2008) Discovery studio, Accelrys [2.1]"},{"key":"2511_CR6","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.3390\/ijms21072431","volume":"21","author":"M Tanaka","year":"2020","unstructured":"Tanaka M, Toldi J, V\u00e9csei L (2020) Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines. IJMS 21:2431. https:\/\/doi.org\/10.3390\/ijms21072431","journal-title":"IJMS"},{"key":"2511_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.25775","volume":"88","author":"RS Turner","year":"2020","unstructured":"Turner RS, Hebron ML, Lawler A, Mundel EE, Yusuf N, Starr JN, Anjum M, Pagan F, Torres-Yaghi Y, Shi W, Mulki S, Ferrante D, Matar S, Liu X, Esposito G, Berkowitz F, Jiang X, Ahn J, Moussa C (2020) Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer\u2019s Disease. Ann Neurol 88:183\u2013194. https:\/\/doi.org\/10.1002\/ana.25775","journal-title":"Ann Neurol"},{"key":"2511_CR46","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E (2021) gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS. J Chem Theory Comput 17:6281\u20136291. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645","journal-title":"J Chem Theory Comput"},{"key":"2511_CR40","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC (2005) GROMACS: Fast, flexible, and free. J Comput Chem 26:1701\u20131718. https:\/\/doi.org\/10.1002\/jcc.20291","journal-title":"J Comput Chem"},{"key":"2511_CR37","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1021\/ci300363c","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe K, MacKerell AD (2012) Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing. J Chem Inf Model 52:3144\u20133154. https:\/\/doi.org\/10.1021\/ci300363c","journal-title":"J Chem Inf Model"},{"key":"2511_CR13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/1479-7364-5-5-485","volume":"5","author":"A Vassilopoulos","year":"2011","unstructured":"Vassilopoulos A, Fritz KS, Petersen DR, Gius D (2011) The human sirtuin family: Evolutionary divergences and functions. Hum Genomics 5:485. https:\/\/doi.org\/10.1186\/1479-7364-5-5-485","journal-title":"Hum Genomics"},{"key":"2511_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13063-021-05273-x","volume":"22","author":"C Verbaanderd","year":"2021","unstructured":"Verbaanderd C, Rooman I, Huys I (2021) Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research. Trials 22:322. https:\/\/doi.org\/10.1186\/s13063-021-05273-x","journal-title":"Trials"},{"key":"2511_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/biof.1032","volume":"38","author":"JM Villalba","year":"2012","unstructured":"Villalba JM, Alca\u00edn FJ (2012) Sirtuin activators and inhibitors. BioFactors 38:349\u2013359. https:\/\/doi.org\/10.1002\/biof.1032","journal-title":"BioFactors"},{"key":"2511_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejmech.2018.10.028","volume":"161","author":"Y Wang","year":"2019","unstructured":"Wang Y, He J, Liao M, Hu M, Li W, Ouyang H, Wang X, Ye T, Zhang Y, Ouyang L (2019) An overview of Sirtuins as potential therapeutic target: Structure, function and modulators. Eur J Med Chem 161:48\u201377. https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.028","journal-title":"Eur J Med Chem"},{"key":"2511_CR27","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer FT, de Beer TAP, Rempfer C, Bordoli L, Lepore R, Schwede T (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-026-02511-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:57:09Z","timestamp":1783331829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-026-02511-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2511"],"URL":"https:\/\/doi.org\/10.1007\/s12031-026-02511-2","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}],"article-number":"49"}}